By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Lab automation company Tecan and ForteBio have partnered to integrate their liquid handling and robotics workstation technologies to provide label-free assays for use in drug discovery and bioprocess research.

The companies have worked together to integrate ForteBio's Octet 384 platform, which includes the RED 384 and the QK384, on Tecan's Freedom EVO liquid handling workstation, Tecan said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.